A group of computer science and engineering students at the Carlos III Universidad in Madrid used natural language processing techniques to translate social-media and forum posts into adverse drug reaction data.
At SXSW, for the first time, health wasn't a breakout topic, but rather a "break-in" topic that had the attention of just about every presenter and attendee.
The personal genetics company created a therapeutics group to extricate new drug targets from its research database.
A recent analysis found that most websites touting personal cancer medicine failed to provide risk data, while an insurer and a health system team up to develop best practices to improve the "how" of genetic testing.
A new survey from Cegedim Relationship Management claims that digital tools are being underutilized and represent an opportunity to meet the demands of HCPs.
FDA approves the first biosimilar, judge rules that FDA panel members had conflicts of interest, and a new venture will evaluate the effectiveness of digital health technologies.
Millennials and baby boomers have a lot of common: a desire for technology that supports health priorities.
Search queries for common diseases on the websites for the CDC and WebMD, among others, are being sent to third-party corporations.
FDA approves Novartis's Farydak for multiple myeloma; Shire acquires rare-disease drug for $70 million; FTC fines melanoma app marketers.
A treatise on understanding the FDA's latest guidance of low-risk general wellness products.
Lilly delays Phase-III cholesterol drug results; PatientsLikeMe and Walgreens team up for "drug reaction reviews"; Roche skin-cancer drug receives Priority Review.
How the adoption of principles from recent, successful start ups can be applied to pharma marketing.
Citing an unnamed source, the paper reports that Apple has abandoned some of the more advanced health monitoring features in its upcoming device, the Apple Watch.
Doximity professional network now includes financial data; Pfizer settles class-action lawsuit; researchers hope to use temporary tattoos to identify glucose levels.
The nighttime sleep aid's Twitter account wrote "Sleep LIKE he finally proposed," last week, a sentiment which didn't resonate positively with the feed's followers.
Google teams up with PwC for DOD EHR project bid; FDA approves first weight-loss device since 2007; research says opioid abuse may be on the decline.
Pop songs about doctors get heavy rotation in BMJ; digital-health investment tally shows doubling in 2014; scientists finger bats as possible Ebola source.
The snag: identifying what qualifies as download-worthy.
A trio of doctors make a case for putting limits on digital promotions, including those in EHRs and through social networks.
Patients want to do more with mobile and see doctors less. Two studies outline the types of digital interventions patients are interested in.
A study by consulting firm Accenture shows that patients not only expect digital outreach, but that their desire to be engaged is consistently being ignored.
A report published by JAMA indicated that online reviews sway a percentage of patients, but that personal recommendations hold more weight.
The move to digitize a series of books it co-created with Disney for kids with type 1 diabetes was spurred by a meeting with the online diabetes community.
Famous from his reality show, "The Osbournes," Jack narrates his life with MS in a web documentary series.
Although doctors still like sales reps, Capgemini and Quantia's researchers find their appeal is on the decline, while digital is on the rise. While age is a factor, it's the workplace that's shaping physician preferences.
Despite a possible government standoff, exchanges are coming, as is a proffered rebrand; Amgen signs a university deal in China; Pakistan seeks to rein in pharma; digital marketing is on the rise, research shows
A good percentage of consumers are open to visiting a pharmaceutical company website, an online survey shows, despite a persistent undercurrent of distrust for industry.
Re-Mission, the video simulation known to change young patients' attitudes toward cancer, is in its second iteration. And one big drug maker has added its backing.
Remedy Health is hoping a new design for its flagship portal can give it an edge over rivals WebMD and Everyday Health.
FDA's Office of Prescription Drug Promotion issued an Untitled Letter over what it says are misleading copy and overstated efficacy claims online.
Proteus Digital Health's ingestible sensor shows utility as an adherence tool for those on psych meds, a study suggests.
The drug maker, through its venture fund, took a controlling interest in the digital physician marketing firm.
The drug maker's broadcast-heavy "OAB reality" campaign stresses the emotional toll on women.
23andMe aired its first TV ad Monday, in a bid to build the audience for DNA sequencing.
The duo whose nonprofit served as neutral ground for getting FDA and industry talking about digital marketing is starting a for-profit research and advisory firm.
An Everyday Health-Twitter collaboration will deliver targeted promoted Tweets with health news, seasonal and lifestyle info
Sanofi named Connect & Coach as the winner of its 2013 Data Design Diabetes contest
Merck came late to the iPad party, but the company has made up the distance by releasing a global template for details using the device.
Pharmas need to start fine-tuning paid search and producing "liquid content" that moves fluidly between screens, said Google's David Blair at our first MM&M Skill Sets Live session
Pharmas are spending far less on reprints and far more on digital promotion to physicians and other healthcare professionals, according to a healthcare media buying specialist.
Pfizer's online Viagra deal with CVS; reorg at the EMA; Mills moves up at Digitas
The FDA wants to know how physician attitudes towards direct-to-consumer advertising have evolved since the agency last asked them, in 2002. If a snap poll by CMI/Compas is any indication, drug companies probably won't like the answers.
Doctors call out Novartis on drug prices; Aubagio shows strong top-line data in trials; and overseas docs increasingly turn to digital.
Sanofi Pasteur scored a pharma first this past winter by offering "Shazam" technology as a way for viewers to interact with TV commercials for its Fluzone Intradermal influenza vaccine—and to find out where they could get the new shot.
WorldOne will use a $35 million financing windfall for a global build-out of the physician social network it acquired in July.
Gwee, who pioneered pharma social media at Vertex before moving onto the agency side, is tasked with integrating digital and social strategies across the marketing and PR network's 14 agencies.
At first blush, Accenture's survey of pharma execs looks like more bad news for sales forces, but the firm tells MM&M that the sales overhauls are about more than reducing headcounts.
Google's latest YouTube update aims to make its Channels more social, and even as the company has given its pharma clients an extra month to hold on to their old page designs, the new format is inspiring anxiety among drug firms and medical agencies.
Epocrates, now under new management, has jettisoned its QuickRecruit offering as it focuses its market research business on pharmas.
Deploying digital frameworks across large pharmaceutical organizations is a tricky business the world over, as execs convening in Barcelona can tell you. Securing local buy-in is essential to a successful multichannel roll-out.
It's not even in beta yet, but Facebook's Graph Search is sending tremors through the advertising landscape. For pharmas, the arrival of social search promises great opportunity -- and many perils.
Remedy Health Media is partnering with the University of California-Berkeley on BerkeleyWellness.com, which will deliver wellness information to consumers with the customary interactive spoonfuls of sugar—quizzes, slideshows, email alerts and social media feeds, along with roundtables and video chats featuring Berkeley experts.
Taking a page from Sanofi, Shire is preparing to launch a developer challenge "to create technology driven solutions that aid individuals with ADHD during the transition from adolescence into adulthood."
A recent paper shows licensing boards may take action for a professional's behavior regardless of whether it is in the context of a professional setting.
Internet trends show fondness for online health information, but no need for docs to take on a third job, Millennium says diabetes device market to grow moderately over five years.
What changes in marketing or audience viewing habits might impact pharma's media investment this year? Media buyers weigh in on the hot channel trends.
From tech shifts to talent, and from emerging markets to engaging with social media, agency execs offer their predictions for what the New Year will bring.
From FDA and pharma, to Caronia and off-label communication, three healthcare policy experts offer their take on what 2013 holds in store.
MDLinx owner M3 Group is partnering with Argentine online CME firm Medcenter on a content-sharing deal that will expand its in-language reach to Spain, Portugal and Latin America.
Biogen Idec sets aside $10M for ALS research, HHS clears eight exchanges.
WebMD is laying off 14% of its workforce in hopes of saving $45 million to offset revenue losses from an ongoing advertising slump that's plagued the portal throughout 2012.
A new campaign from J&J's DePuy Orthopedics, aimed at raising awareness of joint replacement, features Baby Boomers' letters to their younger selves.
R.J. Lewis, President and CEO of e-Healthcare Solutions, offers his unique take on digital pharma trends in a conversation with MM&M Editor in Chief, James Chase. [SPONSORED CONTENT]
Pharma's med/legal/regulatory (MLR) teams, managers of risk and so often the scapegoats for creating roadblocks to digital innovation, were discussed in a much friendlier light by digital marketers at last week's ExL Digital Pharma East conference in Philadelphia.
Pfizer has the strongest social media presence of any pharma, a WEGO Health/Digital Health Coalition poll suggests.
Adrian Sansone is taking over the managing director's seat at Publicis Lifebrands Medicus, and is tasked with changing the way the HCP agency operates.
Privately owned Quadrant HealthCom acquired International Medical News Group (IMNG) from Elsevier, creating a new medical-publishing juggernaut.
Publicis is uniting two of its digital agencies as it seeks to keep the pure-play "e" units competitive.
The fan base of the AMA's publishing arm grew 115% in the second quarter.
A new video-based educational series will aim to tailor content to both patients and physicians, the firms behind the effort say.
Three out of five doctors are now using technology to better communicate with patients, a MedPage Today survey has found, and two-fifths say patients are generally more informed than they were five years ago.
WebMD had to go all the way up to 42nd Street to find its new CEO, Pfizer honcho Cavan Redmond. He brings a keen understanding of the site's biopharma industry advertisers, and he'll need it as the portal looks to shore up flagging ad sales on the consumer side of its business
Physician social network adoption was flat from 2011-2012, a survey says, and Everyday Health gets a nom for a daytime Emmy
Around a third of US adults use social media as a health resource, according to a survey by PricewaterhouseCoopers - whether seeking out medical info, sharing symptoms and experiences or rating drugs, devices, doctors, hospitals and health plans.
Could an online quiz be the future of continuing medical education? In a twist on the "edu-gaming" phenomenon, Cleveland Clinic and physician site MDLinx aim to answer that question with The Smartest Doc, a daily one-minute quiz that aims to keep doctors up to date on the medical literature by appealing to their competitive spirit.
There have been multiple promises by pharma to change its sales and marketing approach. Booz & Co. partner Danielle Rollmann says the time for promises is over, and action needs to happen, particularly in the digital space. Now.
Sermo is searching for a CEO and a medical advisory board since the physician online community's founder, Dr. Daniel Palestrant, and chief medical officer, Dr. Adam Sharp, left in November to launch a new startup called Par8o.
GlaxoSmithKline is souping up its social media monitoring with a digital strategy it says will create processes that are standard enough to streamline communications, but flexible enough to meet local requirements.
Healthcare Q&A site Sharecare is buying RealAge from Hearst for an undisclosed sum, the companies said.
Novartis named Brian McNamara as division head of OTC, replacing J&J veteran Naomi Kelman, who spent a year in the role.
Novo Nordisk has launched a big integrated Spanish-language marketing campaign for its FlexPen insulin delivery device - one that Univision calls "the most robust ever" in Hispanic media for the diabetes sector.
Weary of FDA foot-dragging on digital and social media guidance for pharmas, a group of 60-some industry digerati have put together guidelines of their own.
Procter & Gamble is looking to lower its promotion costs by leaning more on digital media, Chairman and CEO Bob McDonald told analysts in an earnings call.
Novo Nordisk is courting controversy with a Victoza-branded type 2 diabetes education campaign featuring Southern-fried celebrity chef Paula Deen and her sons.
WebMD scrapped plans for a possible sale and announced that president and CEO Wayne Gattinella is stepping down after 11 years in that role.
Healthline Networks has secured a deal with Drugs.com giving it exclusive rights to sell consumer ads on the site, which boasts 8.8 million unique visitors per month.
Merck's Global Health Innovation Fund (GHIF) is investing up to $17 million in Physicians Interactive, a company that develops digital products for doctors such as e-sampling and interactive education programs.
Mobile campaigns are getting increasingly targeted through layering of identifiers like location, age and gender. An effort for a new thermometer serves ads only to expecting moms and those with children under five within two miles of a store selling the device and only when influenza is running rampant where they live.
WebMD's talks with private equity firms come amid an advertising slump, and going private could buy the firm time to retool its business model while insulating it from activist investors like Carl Icahn.
Jon Bon Jovi is the latest celebrity pitchman for Pfizer Consumer Healthcare's Advil.
Health information site HealthCentral has been acquired by Remedy Health, a multimedia provider of content and tools designed to help people manage disease, the firms said today.
Consumers are as worried about online privacy as they are about terrorism, but marketers tracking their surfing habits or mining their emails for insights is the least of their worries, according to a survey by McCann Truth Central.
Boehringer Ingelheim is hoping to create a new Facebook phenomenon with the development of a pharma civilization game that could give industry reputation a shot in the arm.
More than a quarter of posts on Facebook sites for people with diabetes are promotional in nature, many touting products unapproved by the FDA, according to an analysis of diabetes-focused social networks.
Underscoring the importance of social media in public health, patients say friends and family are as responsible for their health as are medical professionals, according to Edelman's 2011 Health Barometer study.
A survey by Yahoo! and advertising giant BBDO says advertisers need to raise their game in "owned media" like brand.com sites to woo consumers.
Asking consumers to gauge their risk for non-adherence, Merck is deploying a one-minute survey dubbed the Adherence Estimator that may be the way forward for keeping patients on-treatment.
He takes a very direct approach to the pursuit of prostate health. He's Branko the Prostate Czech, and he's been wielding his latex glove to raise awareness during September's Prostate Cancer Awareness Month.
Novo Nordisk is getting in on the boom in electronic publishing with a series of e-books available through its Cornerstones4Care patient support program.
Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.
- US pharma market value projected to be $550 billion in five years
- Biosimilar uptake will require companies to tell a trustworthy backstory
- Lawmakers propose allowing pharma companies to share some off-label information
- Apple's ResearchKit: Five Guidelines for Pharma
- Everyday Health buys rare-disease agency Cambridge BioMarketing